UnitedHealth Group (NYSE:UNH) Given New $610.00 Price Target at Truist Financial

UnitedHealth Group (NYSE:UNH - Free Report) had its price objective lowered by Truist Financial from $625.00 to $610.00 in a report published on Monday, Marketbeat Ratings reports. The firm currently has a buy rating on the healthcare conglomerate's stock.

Several other analysts have also recently issued reports on the company. Oppenheimer upped their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. Royal Bank of Canada lowered their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a research report on Wednesday, October 16th. Bank of America decreased their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating on the stock in a research note on Thursday. Finally, Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a report on Thursday, December 5th. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $627.58.

UnitedHealth Group Price Performance

UNH traded down $1.05 on Monday, hitting $511.95. 4,443,919 shares of the company's stock traded hands, compared to its average volume of 3,900,475. UnitedHealth Group has a one year low of $436.38 and a one year high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $471.14 billion, a price-to-earnings ratio of 33.35, a P/E/G ratio of 1.53 and a beta of 0.62. The company's 50 day simple moving average is $558.76 and its 200-day simple moving average is $561.51.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analysts' expectations of $99.14 billion. During the same period last year, the company posted $6.56 earnings per share. UnitedHealth Group's quarterly revenue was up 9.2% on a year-over-year basis. As a group, research analysts anticipate that UnitedHealth Group will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.64%. UnitedHealth Group's dividend payout ratio is currently 54.72%.

Hedge Funds Weigh In On UnitedHealth Group

Institutional investors have recently bought and sold shares of the business. Delta Financial Group Inc. lifted its stake in shares of UnitedHealth Group by 1.0% during the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate's stock worth $965,000 after purchasing an additional 17 shares during the last quarter. Fiduciary Group LLC grew its position in shares of UnitedHealth Group by 0.5% in the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate's stock worth $1,882,000 after buying an additional 18 shares during the last quarter. First PREMIER Bank lifted its position in UnitedHealth Group by 7.0% during the third quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate's stock valued at $160,000 after acquiring an additional 18 shares during the last quarter. Genesee Capital Advisors LLC grew its holdings in UnitedHealth Group by 1.9% in the third quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate's stock worth $579,000 after purchasing an additional 18 shares during the last quarter. Finally, Jmac Enterprises LLC lifted its holdings in shares of UnitedHealth Group by 2.2% during the 3rd quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate's stock valued at $481,000 after purchasing an additional 18 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.